MERILEE RAINES
CIK 1023869 · Executive VP & CFO · last filed 2026-08-04
MERILEE RAINES is an Executive VP & CFO who has filed 68 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for WTS, was dated Aug 4, 2026. Across all open-market trades the lifetime net is −$38.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $34.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$34.49M
7
68
-$38.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WTS | Director | 21,670 | $377.12 | $8.17M | $0 | 17 | 2026-08-04 |
| OCUL | Director | 60,933 | $8.74 | $532.6K | $0 | 6 | 2026-06-12 |
| TMDX | Director | 6,981 | $80.21 | $559.9K | $0 | 7 | 2026-05-22 |
| BHE | Director | 24,489 | $82.37 | $2.02M | $0 | 3 | 2021-05-14 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 7 | 2019-07-18 |
| AFFYMETRIX INC (AFFX) Delisted | Director | 0 | — | — | $0 | 3 | 2016-04-01 |
| IDXX | Executive VP & CFO | 39,332 | $590.00 | $23.21M | -$38.68M | 25 | 2013-02-27 |
Recent Filings
68 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-08-04 | WTS | Grant (A) | +456 | $0 | EDGAR |
| 2026-06-12 | OCUL | Grant (A) | +14,000 | $0 | EDGAR |
| 2026-05-22 | TMDX | Grant (A) | +2,922 | $0 | EDGAR |
| 2025-08-05 | WTS | Grant (A) | +516 | $0 | EDGAR |
| 2025-06-13 | OCUL | Grant (A) | +14,000 | $0 | EDGAR |
| 2025-05-23 | TMDX | Grant (A) | +2,134 | $0 | EDGAR |
| 2024-08-05 | WTS | Grant (A) | +678 | $0 | EDGAR |
| 2024-07-26 | OCUL | Grant (A) | +12,000 | $0 | EDGAR |
| 2024-05-28 | TMDX | Grant (A) | +732 | $0 | EDGAR |
| 2023-07-31 | WTS | Grant (A) | +713 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.